3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Recurrence
1
Postoperative Hemorrhage
1
Postoperative Complications
1
Myofibroma
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Leiomyoma
1
Blood Loss, Surgical
1
Interventions
Azacitidine
10
Decitabine
9
Cyclophosphamide
9
Cytarabine
7
Tacrolimus
6
Antilymphocyte Serum
6
fludarabine phosphate
5
Mycophenolic Acid
5
Melphalan
5
Busulfan
5
fludarabine
4
Whole-Body Irradiation
4
Peripheral Blood Stem Cell Transplantation
4
Idarubicin
4
Rituximab
3
Polymerase Chain Reaction
3
Lenalidomide
3
Filgrastim
3
venetoclax
2
sargramostim
2
Tretinoin
2
Radiotherapy
2
Methylprednisolone
2
Methotrexate
2
Flow Cytometry
2
Etoposide
2
Cyclosporine
2
Cord Blood Stem Cell Transplantation
2
Clofarabine
2
Blood Specimen Collection
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Myelodysplastic Syndromes
×
Tranylcypromine
×
Clear all
NCT02717884
2018-10-18
TRANSATRA
University Hospital Freiburg
Phase 1/2
Unknown
60 enrolled